COR vs LIN · P/E 21, rev $321.33B vs P/E 34, rev $33.99B
Cencora Inc. (COR) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
COR currently screens at market cap $53.91B and trailing P/E 21.2. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the COR and LIN stock pages for the full models.
Not investment advice.